Like Causes?

Install the App
TRY NOW

senate Bill S. 916

Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018

Bill Details

Official information provided by the Congressional Research Service. Learn more or make a suggestion.
The Congressional Research Service writes summaries for most legislation. These summaries are listed here. Causes will update some legislation with a revised summary, title or other key elements.

Suggest an update to this bill using our form.

Title

Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018

Official Title

To amend the Controlled Substances Act to provide for the delivery of a controlled substance by a pharmacy to an administering practitioner.

Summary

Protecting Patient Access to Emergency Medications Act of 2017 (Sec. 2) This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration (DEA) to register an emergency medical services (EMS) agency to administer controlled substances if the agency submits an application demonstrating that it is authorized to conduct such activity in the state in which the agency practices. The DEA may deny an application if it determines that the registration is inconsistent with the public interest. An EMS agency may obtain a single registration in each state instead of a separate registration for each location. A registered EMS agency may deliver, store, and receive controlled substances, subject to specified conditions. An EMS professional of a registered EMS agency may administer controlled substances in schedules II, III, IV, or V outside the physical presence of a medical director if such administration is authorized under state law and pursuant to a standing or verbal order, subject to specified conditions. The bill specifies that a hospital-based EMS agency (i.e., an EMS agency owned or operated by a hospital) may continue to administer controlled substances under the hospital's DEA registration. (Sec. 3) A pharmacy may deliver a controlled substance to an administering practitioner in accordance with this bill's requirements, subject to specified conditions. The Government Accountability Office must report to Congress on access to and the potential diversion of controlled substances administered by injection, implantation, or through the use of an intrathecal pump.

bill Progress


  • Not enacted
    The President has not signed this bill
  • The house has not voted
  • The senate Passed May 23rd, 2018
    Passed by Voice Vote
      senate Committees
      Committee on Health, Education, Labor, and Pensions
    IntroducedApril 24th, 2017

Log in or create an account to see how your Reps voted!